Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 04 Aug 2026 for Nurix Therapeutics, Inc., €37k. Read the official filing
Filing timeline
BuySaleHans van Houte
Insider track record
Disclosed buys
0
Disclosed sells
16
Signal history
Hans van Houte: trading record in brief
This profile gathers the share dealings of Hans van Houte in Nurix Therapeutics, Inc., where the filings describe the role as finance chief. The record holds 39 filings, for trades running from 30 April 2022 to 4 August 2026.
No open-market purchase appears, only 16 sales worth €1.7M. Besides market trades, the filings include 23 option exercises. 2026 to date brings no purchases and 4 sales.
Most recently, on 4 August 2026, the filings show an open-market sale worth €37k in Nurix Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hans van Houte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
1,794 shares@ US$23.89110.0017% mcap2.2% of flowCommon StockSEC:0001817217-26-000012:0
2,967 shares@ US$24.64740.0029% mcap3.7% of flowCommon StockSEC:0001817217-26-000012:1
3,750 shares0Common StockSEC:0001817217-26-000010:0
2,858 shares0Common StockSEC:0001817217-26-000010:1
3,572 shares0Common StockSEC:0001817217-26-000010:2
2,845 shares@ US$23.38280.0027% mcap3.4% of flowCommon StockSEC:0001817217-26-000010:3
2,000 shares0Common StockSEC:0001817217-26-000006:0
2,858 shares0Common StockSEC:0001817217-26-000006:2
2,388 shares@ US$16.64530.0016% mcap2.0% of flowCommon StockSEC:0001817217-26-000006:3
3,750 shares0Common StockSEC:0001817217-26-000006:1
2,887 shares0Common StockSEC:0001817217-26-000002:0
6,284 shares@ US$12.56074.0% of flowCommon StockSEC:0001817217-25-000005:0
2,886 shares0Common StockSEC:0001817217-25-000003:0
5,402 shares@ US$11.03253.1% of flowCommon StockSEC:0001549595-25-000103:0
2,886 shares0Common StockSEC:0001549595-25-000101:0
6,198 shares@ US$11.33313.6% of flowCommon StockSEC:0001549595-25-000063:0
2,886 shares0Common StockSEC:0001549595-25-000059:0
5,125 shares@ US$14.39944.1% of flowCommon StockSEC:0001549595-25-000037:0
2,886 shares0Common StockSEC:0001549595-25-000020:0
3,546 shares@ US$24.27624.6% of flowCommon StockSEC:0001549595-24-000153:0
2,886 shares0Common StockSEC:0001549595-24-000148:0
20,000 shares@ US$25.218526.4% of flowCommon StockSEC:0001549595-24-000112:0
3,377 shares@ US$21.42553.9% of flowCommon StockSEC:0001549595-24-000110:0
2,886 shares0Common StockSEC:0001549595-24-000104:0
20,000 shares@ US$20.010821.9% of flowCommon StockSEC:0001549595-24-000088:0
25 of 39 declarations
